重度大麻使用与抗逆转录病毒治疗HIV感染者活化及炎症免疫细胞频率降低相关
在198例接受抗逆转录病毒治疗的HIV感染者中,按血浆大麻代谢物THC-COOH水平分为重度、中度、偶尔及不使用者,用流式细胞术评估外周免疫细胞频率、活化与功能。重度使用者较不使用者HLA-DR+CD38+CD4+和CD8+ T细胞频率降低,中间型和非经典单核细胞亚群频率降低,产生IL-23和TNF-α的抗原提呈细胞频率降低。作者认为临床意义尚不明确,但提示大麻使用与潜在有益的系统性炎症和免疫活化降低相关。
要点
- 重度大麻使用者HLA-DR+CD38+CD4+和CD8+ T细胞频率较不使用者降低。
- 重度大麻使用者中间型和非经典单核细胞亚群频率降低。
- 重度大麻使用者产生IL-23和TNF-α的抗原提呈细胞频率降低。
核心结论
- 作者认为临床意义尚不明确,但发现提示在抗逆转录病毒治疗的HIV感染背景下,大麻使用与潜在有益的系统性炎症和免疫活化降低相关。
研究设计与样本
- 在198例接受抗逆转录病毒治疗的HIV感染者中,通过质谱法检测血浆大麻代谢物11-去甲-羧基-四氢大麻酚(THC-COOH)水平,将个体分为重度、中度、偶尔大麻使用者或不使用者,并用流式细胞术评估外周免疫细胞频率、活化与功能。
主要发现
- 重度大麻使用者较不使用者HLA-DR+CD38+CD4+和CD8+ T细胞频率降低。
- 重度大麻使用者中间型和非经典单核细胞亚群频率降低。
- 重度大麻使用者产生白细胞介素23和肿瘤坏死因子-α的抗原提呈细胞频率降低。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Cannabis is a widely used drug in the United States, and the frequency of cannabis use in the human immunodeficiency virus (HIV)-infected population is disproportionately high. Previous human and macaque studies suggest that cannabis may have an impact on plasma viral load; however, the relationship between cannabis use and HIV-associated systemic inflammation and immune activation has not been well defined. METHODS: The impact of cannabis use on peripheral immune cell frequency, activation, and function was assessed in 198 HIV-infected, antiretroviral-treated individuals by flow cytometry. Individuals were categorized into heavy, medium, or occasional cannabis users or noncannabis users based on the amount of the cannabis metabolite 11-nor-carboxy-tetrahydrocannabinol (THC-COOH) detected in plasma by mass spectrometry. RESULTS: Heavy cannabis users had decreased frequencies of human leukocyte antigen (HLA)-DR+CD38+CD4+ and CD8+ T-cell frequencies, compared to frequencies of these cells in non-cannabis-using individuals. Heavy cannabis users had decreased frequencies of intermediate and nonclassical monocyte subsets, as well as decreased frequencies of interleukin 23- and tumor necrosis factor-α-producing antigen-presenting cells. CONCLUSIONS: While the clinical implications are unclear, our findings suggest that cannabis use is associated with a potentially beneficial reduction in systemic inflammation and immune activation in the context of antiretroviral-treated HIV infection.
引用
- Manuzak JA, Gott TM, Kirkwood JS, et al. Heavy Cannabis Use Associated With Reduction in Activated and Inflammatory Immune Cell Frequencies in Antiretroviral Therapy-Treated Human Immunodeficiency Virus-Infected Individuals. Clin Infect Dis. 2018. PMID: 29471387. doi:10.1093/cid/cix1116
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。